Robert Weinkove

21PUBLICATIONS
90CO-AUTHORS
Language documentation and descriptionRespiratory diseasesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 07, 2026
Australasian chronic lymphocytic leukaemia consensus statement: 2026 update.

|Feb 12, 2026
Prevention and management of febrile neutropenia in acute myeloid leukaemia and higher risk myelodysplastic syndrome: An international survey of current practice.

Aleece MacPhail, Justin Loke, Brett L Houston

|Jan 13, 2026
Blood tests to predict CAR T-cell toxicity and efficacy.

Robert Weinkove, Ellie-May Jarvis

|Aug 27, 2025
The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL.

Othman Al-Sawaf, Moritz Fürstenau, Adam Giza

|Sep 24, 2024
Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE.

Jennifer R Brown, Barbara Eichhorst, Nicole Lamanna

|Apr 09, 2024
Immunoglobulin replacement vs prophylactic antibiotics for hypogammaglobulinemia secondary to hematological malignancy.

Zoe K McQuilten, Robert Weinkove, Le Thi Phuong Thao

Pageof 4

Frequent Collaborators

6 joint publications

Zoe McQuilten

5 joint publications

Erica M Wood

3 joint publications

Tadeusz Robak

3 joint publications

Tara Cochrane